Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott's Piramal Acquisition Is $3.72 Billion Push In Emerging Markets With Established Products

Related Content

Sanofi Beats GSK To Buy Merieux Alliance's Stake In India's Shantha Biotech; Move Aimed At Stronger Vaccines Business In Emerging Markets

Jul 27 2009

Pfizer Delves Deeper In Generics Partnership With Strides Arcolab

May 17 2010

Abbott Ups Emerging Markets Ante With Zydus Deal, Established Products Unit

May 13 2010

Ten Months On, Abbott, Wockhardt Terminate Deal For Nutritional Business

Apr 01 2010

Hospira To Acquire Injectable Drug Business Of India's Orchid Pharmaceuticals

Dec 16 2009

Piramal Close To Buying Local Critical Care Brands With An Eye On Global Markets

Apr 22 2010

As Ranbaxy Founders Exit, Daiichi Sankyo Assumes Complete Control; New Management Expects To Resolve U.S. FDA Issue

May 25 2009

More from Archive

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window